Chiara Corti: Our ASCO Daily News editorial “IMpassion132”

Chiara Corti shared a post on LinkedIn:

“Check out our American Society of Clinical Oncology (ASCO) Daily News editorial ‘IMpassion132: Learning From Immunotherapy’s Failures in Early Relapsing Triple-Negative Breast Cancer’. ”

Source: Chiara Corti/LinkedIn

More posts by Chiara Corti in OncoDaily.

Chiara Corti is currently a Clinical Research Fellow at Dana-Farber Cancer Institute in Boston, focusing on early drug development for patients with solid tumors, with a special commitment to breast cancer. Since November 2019, she has also been a Medical Oncology Fellow at the European Institute of Oncology (IEO).